US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: Strong Analyst Consensus and 31% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing the attention of investors with its robust growth potential and strong market performance. Currently headquartered in..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Potential 16.53% Upside in the Booming Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $9.14 billion, Repligen is..

Qiagen N.V. (QGEN) Stock Report: Exploring a 10.95% Potential Upside in the Diagnostics & Research Sector

For investors keen on the healthcare sector, Qiagen N.V. (NYSE: QGEN) offers a compelling opportunity with a market cap of $9.88 billion. Specializing in diagnostics and research, Qiagen is a..

Johnson & Johnson (JNJ) Stock Analysis: Poised for Steady Growth with a 1.42% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to present a promising opportunity for investors seeking stability and growth in a volatile market. With a market..

Charles River Laboratories (CRL) Stock Analysis: Is the Market Overlooking This Healthcare Giant?

Charles River Laboratories International, Inc. (CRL), a prominent player in the healthcare sector’s diagnostics and research industry, is drawing attention with its robust market presence and strategic collaborations. With a..

Glaukos Corporation (GKOS) Stock Analysis: Investor Confidence Grows with Strong Buy Ratings

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable interest from investors. With a market capitalization of $6.68 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating a High-Growth Path in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands at the forefront of the healthcare sector, specifically within diagnostics and research. With a market capitalization of $19.32 billion, the company has carved a..

Elanco Animal Health (ELAN) Stock Analysis: Unpacking a 12% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) is drawing attention from the investment community with a calculated potential upside of 12.11%, according to analyst ratings. With its headquarters in Greenfield, Indiana,..

Investor Outlook: Bruker Corporation (BRKR) Shows Promising 11.42% Upside Potential Amid Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR), a leading player in the healthcare sector, stands at an intriguing juncture for investors seeking opportunities in the medical devices industry. With a market capitalization of..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating Growth Potential with an 8.29% Upside

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, continues to attract attention for its unique position in the medical instruments and supplies industry. With a diverse portfolio..

BioNTech SE (BNTX) Stock Analysis: Navigating a Potential 49.82% Upside in the Biotech Arena

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been making headlines with its innovative approaches to treating cancer and infectious diseases. Based in Mainz, Germany, this..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Gem with 172% Potential Upside

Telix Pharmaceuticals Limited (NASDAQ: TLX), a prominent player in the biotechnology industry, has been making waves with its innovative approaches to cancer treatment. Headquartered in North Melbourne, Australia, this commercial-stage..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking a Potential 39% Upside in Healthcare Innovation

Stevanato Group S.p.A. (STVN), a formidable player in the medical instruments and supplies industry, is strategically positioned in the healthcare sector with a market cap of $5.6 billion. Headquartered in..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27.55% Upside Potential Beckons Investors

Investors on the lookout for promising opportunities in the biotechnology sector should turn their attention to Jazz Pharmaceuticals plc (NASDAQ: JAZZ). With a market capitalization of $10.15 billion, this Dublin-based..

Quest Diagnostics (DGX) Stock Analysis: 12.5% Upside Potential Amid Strong Revenue Growth

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, particularly within the Diagnostics & Research industry. With a substantial market capitalization of $19.69 billion, the..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Exploring an 18.97% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a Japanese pharmaceutical giant with a rich history dating back to 1781, stands as a stalwart in the global healthcare sector. With a market..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a Promising 12.84% Upside Potential

For investors seeking opportunities in the biotech sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) offers an intriguing proposition. With a market capitalization of $7.92 billion, the company is a prominent player..

Teva Pharmaceutical Industries (TEVA): Investor Outlook on a Promising 7.98% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a heavyweight in the healthcare sector, has been a compelling name in the pharmaceutical landscape. Specializing in the development, manufacturing, and distribution of generic..

Genmab A/S (GMAB) Stock Analysis: A Lucrative 16.78% Upside Awaits Investors

Genmab A/S (NASDAQ: GMAB) is drawing significant attention in the biotechnology sector, offering a promising potential upside of 16.78% according to current analyst targets. Based in Copenhagen, Denmark, this biotech..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the 18.84% Potential Upside with Strong Buy Ratings

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is capturing investor attention with its robust market presence in the diagnostics and research industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds